Ongoing conflict involving Iran has created oil market disruptions, benefiting traders while prompting monetary policy adjustments and supply concerns.
A Manhattan federal jury ruled that Live Nation and its Ticketmaster subsidiary illegally monopolized the live event ticketing market after a lawsuit by dozens of states.
China's first quarter GDP growth of 5% exceeded expectations, driven by strong exports, while financial markets showed varied results.
Several major corporations announced significant deals, partnerships, and strategic shifts across various sectors this week.
The International Monetary Fund reduced its UK growth projection to 0.8% this year, marking the largest downgrade among G7 nations.
Charles Schwab posted strong quarterly earnings growth driven by increased trading activity and announced plans to offer direct bitcoin and ethereum trading.
Several major U.S. banks including Bank of America, Morgan Stanley, and PNC reported first-quarter profits that exceeded analyst expectations.
Spirit Airlines is reportedly considering liquidation as early as this week as the budget carrier struggles with rising fuel costs and creditor negotiations.
Kering announced an ambitious restructuring plan aimed at doubling profits while restoring financial discipline and refreshing Gucci's creative direction.
Federal Reserve policy direction remains unclear as markets anticipate cautious approach while Kevin Warsh's nomination progresses through Senate.
Tax filing deadline approaches amid funding market concerns and polling showing majority of Americans feel overtaxed.
United Airlines CEO reportedly explored a possible business combination with rival American Airlines in discussions.
U.S. regulators are examining potentially suspicious trading patterns that occurred before market-moving announcements from President Trump.
A Gallup poll indicates more young men are regularly attending religious services and consider religion important in their lives.
JPMorgan and Wells Fargo delivered mixed earnings results while Johnson & Johnson exceeded forecasts driven by cancer drug sales and raised its dividend.
Page 1 of 38 (559 stories)